Market News AIOpen the app

Evogene lost about $2.9 million last quarter, down from a $5.2 million profit a year earlier.

ResultsRead the original at prnewswire.com
Bad for EVGN

Evogene’s sales fell to $0.1 million from $0.3 million, and it reported a $2.9 million loss. The prior-year profit mainly came from ICL transaction income; research programs advanced, and it held $9.2 million in cash, but no new program results or sales were reported.

EVGN · Evogene Ltd.

AI read · Bad for EVGN

The AI's read

The prior-year profit came mainly from income tied to the ICL transaction, so the profit-to-loss change does not tell the whole story. Sales still fell after the Bayer agreement ended. Research programs advanced, but the report gave no new results or sales from those efforts.

Get alerts for EVGN

Follow Evogene Ltd. (EVGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EVGN
Free on the App Store and Google Play, or on the web.